Skip to content
Review Open access

The asthma-obstructive sleep apnea overlap: pathophysiological links, clinical impact, and implications for integrated management

Nov 2026 · Exploration of Asthma & Allergy · Vol 4 · 0 citations · 59 references

TL;DR

An integrated mechanistic framework encompassing mechanical/neuroreflex interactions, intermittent hypoxia–driven inflammation/oxidative stress, and metabolic dysfunction is constructed encompassing mechanical/neuroreflex interactions, intermittent hypoxia–driven inflammation/oxidative stress, and metabolic dysfunction.

Abstract

The asthma-obstructive sleep apnea (OSA) overlap is a clinically important phenotype, especially in patients with severe or difficult-to-control asthma. Rather than a simple coexistence of independent conditions, this overlap represents a distinct clinical entity modulated by shared pathobiological pathways. This review integrates epidemiologic data, critically balancing association and causation across shared risk factors (obesity, GERD, upper airway disease). We construct an integrated mechanistic framework encompassing mechanical/neuroreflex interactions, intermittent hypoxia–driven inflammation/oxidative stress, and metabolic dysfunction. The overlap is associated with poorer asthma control, increased nocturnal symptoms, reduced quality of life, and higher healthcare utilization. Current evidence is largely observational; randomized controlled trials with respiratory endpoints and prospective cohorts with repeated polysomnography and biomarker panels are needed to establish strict bidirectional causality and identify responders to targeted therapies. A multidisciplinary, treatable-traits approach addressing OSA, obesity, rhinitis, GERD, and inhaler optimization is recommended while awaiting mechanistic and interventional data on CPAP, weight-loss therapies, and biologics.

Read PDF

Similar papers

Review Open access Oct 2026

Functional dyspepsia and obstructive sleep apnea syndrome: the links and therapy

Functional dyspepsia (FD) and obstructive sleep apnea syndrome (OSAS) are prevalent conditions that often coexist, linked by shared risk factors and overlapping mechanisms such as circadian disruption, autonomic imbalance, inflammation, gut–brain axis dysfunction, and microbiome alterations. Evidence suggests a bidirec...

M. Salem, E. Dongol, Haggagy Mansour et al. · 0 citations
Review Open access Sep 2026

Dietary Approaches to Obstructive Sleep Apnea: Translating Mechanistic Pathways into Clinical Practice

Obstructive sleep apnea (OSA) is a highly prevalent and heterogeneous sleep disorder characterized by recurrent upper airway collapse during sleep, resulting in intermittent hypoxia, sleep fragmentation, sympathetic activation, and increased cardiometabolic risk. Although obesity is the most recognized modifiable risk...

T. P. Minari, J. Vilela-Martin, L. Pisani · 0 citations
Oct 2026

How obstructive sleep apnea differs in COPD and asthma: insights from a clinical and functional study

OVS showed greater nocturnal hypoxemia and respiratory events, whereas aOVS showed more frequently recorded awakenings, insomnia symptoms and fatigue, and the trend emerging from the differing prevalence of predicted LowAT appears interesting but is currently exploratory.

A. Fabozzi, A. Steffanina, A. Nicolai et al. · 0 citations
Review Oct 2026

Weight Management in Obesity-Associated Sleep-Disordered Breathing: Mechanisms, Clinical Management, and Emerging Therapies.

OBJECTIVE To review the mechanistic links between obesity and sleep-disordered breathing (SDB) and summarize practical approaches to weight-directed, sleep-directed, and phenotype-informed management. METHODS We conducted a focused narrative review of clinical trials, systematic reviews, meta-analyses, guidelines, an...

Ron T. Varghese, Isabella Sharifi, Sneha Akurati · 0 citations
Review Open access Nov 2026

Crosstalk mechanisms, clinical correlations and therapeutic implications linking OSA with HFpEF progression

Obstructive sleep apnea (OSA) is closely associated with and represents a potential biological contributor to the onset and progression of heart failure with preserved ejection fraction (HFpEF). Although abundant studies have clarified the associations of OSA with cardiovascular diseases including hypertension, coronar...

Wei-Tong Zhao, Jian-Chang Xie, Tao Lyu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.